CFMG & Wellpath in California — a documentary investigation · Article 012 of 100 · Series 2 — Inside the management agreement

The Other Half of the MSA: How Broad the Management Grant Really Is

Published

20 September 2026, 6:00 PM PT

Content last changed

20 September 2026, 6:00 PM PT

Public-evidence cutoff

20 September 2026, 6:00 PM PT

Sources checked

20 September 2026, 6:00 PM PT

Record through

20 September 2026, 6:00 PM PT

Editorial status

Public-source editorial review complete

Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.

Opening frame#

The Other Half of the MSA: How Broad the Management Grant Really Is turns on the difference between authority written on paper and authority demonstrated in operation. The analysis reads the management-services architecture as a division of functions, then tests whether the economic and administrative structure supports, constrains, or leaves unanswered the professional authority formally reserved to CFMG.

The governing question is narrow: What systems did the manager control or administer around the medical practice? The article connects that question to juridical identity, operational integration, professional authority, ownership and succession, practical exit rights, and demonstrated veto power only where the evidence makes those connections material.

I. The Question and the Public Record#

The relevant public record is best read cumulatively. No single branding statement, county agenda item, corporate filing, bankruptcy disclosure, or management agreement resolves the entire relationship. The evidentiary value comes from comparing documents created for different purposes and asking whether they converge on the same allocation of identity, authority, economics, and professional responsibility.

The litigation record does not support a single consistent public position that:

“CFMG and Wellpath are always the same entity.”

Nor does it support the opposite proposition:

“CFMG and Wellpath operate as completely independent companies.”

Instead, the record shows a recurrent issue-dependent duality .

When formal corporate identity became dispositive after Chapter 11, parties repeatedly stipulated or acknowledged that CFMG was separate and distinct from Wellpath and had to be added as the actual or necessary professional-corporation defendant.

But in other litigation contexts—especially discovery, financial condition, records, employment administration, and institutional knowledge—the record shows substantial practical integration.

The most extreme example is Smith v. Santa Cruz County , where the parties stipulated, at CFMG’s request, that:

for purposes of that lawsuit, CFMG and Wellpath were for “all intents and purposes the same entity,” such that no distinction would be drawn between them.

In July 2026, the district court held CFMG to that stipulation in a punitive-damages/financial-discovery dispute and rejected CFMG’s attempt to narrow the stipulation after it had benefited from reduced discovery.

At the opposite end of the spectrum are post-bankruptcy cases such as Reynolds , Pugh , J.S. , Yang , Madrid , and Johnson , where the court record became more exact about CFMG being a distinct, nondebtor entity or actual contracting party.

Overfield supplies a third category: the corporate entities remain formally distinct, yet CFMG produced a Wellpath executive as its Rule 30(b)(6) witness about a CFMG physician termination, and that executive testified the physician was terminated by management working for Wellpath.

The litigation census therefore suggests a more defensible synthesis:

CFMG’s legal separateness is real, but the degree of functional integration with Wellpath has been sufficiently deep that CFMG itself has, in at least one case, accepted complete litigation interchangeability, while other cases expose shared HR, records, financial, risk, and management infrastructure. Bankruptcy made the formal boundary impossible to ignore and forced later cases to identify the professional corporation more precisely.

That is not alter-ego adjudication.

It is a documented history of shifting relevance of the corporate boundary.

II. Structural and Historical Context#

What the timeline does not answer#

The corporate history tells us who appeared where.

It does not yet answer:

• who owned CFMG shares during every period;

• what rights were contained in the CFMG-specific stock-transfer restriction agreements;

• whether CFMG could replace Wellpath as manager without significant contractual consequences;

• how formal physician authority operated in practice;

• or which entity had the last word in a disputed physician-reserved decision.

Those are subjects for the management-architecture, litigation and authority-map pages.

III. The Control and Governance Analysis#

Why California law makes that distinction important#

The Medical Board of California says the state’s corporate-practice doctrine is intended to prevent unlicensed persons from interfering with physician professional judgment. Its current guidance identifies decisions such as diagnostic testing, referrals, ultimate patient care, physician workload and hours, clinically related hiring or firing, medical-record control, coding and billing, and medical-equipment decisions as areas in which physician authority matters. The Board says an MSO may be consulted, but the licensed physician must retain ultimate responsibility or approval for decisions that cannot be delegated. Source: Medical Board of California

That does not mean a large MSO is inherently unlawful.

It means the boundary matters .

The statutory foundation#

California Business and Professions Code §2400 states, subject to statutory exceptions, that corporations and other artificial entities have no professional rights, privileges or powers. BPC §2400

Business and Professions Code §2052 prohibits the unlicensed practice of medicine and addresses persons who aid or assist unlicensed practice. BPC §2052

California simultaneously permits professional corporations organized under its professional-corporation statutes. Corporations Code §13401.5 identifies categories of licensed professionals who may participate in specified professional corporations and limits the aggregate ownership of certain non-physician licensed professionals in a medical corporation. Corporations Code §13401.5

The practical result is not “corporations cannot be involved in healthcare.”

It is that California draws a line between:

• a professional corporation through which licensed professionals exercise professional powers; and

• a management organization that may provide administrative infrastructure without taking the professional powers for itself.

Records, coding and equipment are not merely back-office subjects#

The same point applies to systems that may look administrative.

A management company can provide recordkeeping technology.

But the Board treats substantive control of medical records as a physician issue.

A management company can process billing.

But the Board identifies coding and billing procedures as an area of physician control.

A management company can procure equipment.

But the Board includes approval of medical equipment and supplies in its physician-control guidance.

The analysis therefore turns on the difference between administration and final substantive authority .

Layer two: an exclusive management relationship#

The agreement makes the management company CFMG’s exclusive provider of management services .

The manager is authorized to perform those services in the manner it considers reasonably appropriate to meet the day-to-day business needs of CFMG, subject to the agreement and applicable law.

This is not a narrow payroll contract.

Exhibit B describes a broad operating platform.

Among the functions assigned to the manager are categories involving:

• legal and regulatory support;

• accounting and finance;

• payroll and tax administration;

• benefit-plan administration;

• administrative personnel;

• information technology;

• database and connectivity services;

• electronic medical-record implementation and maintenance;

• insurance and risk management;

• billing and collections;

• record-maintenance infrastructure;

• supplies and support services;

• purchasing;

• marketing and bidding assistance;

• and office support.

The correct conclusion is straightforward:

The contract contemplated extensive administrative integration from the beginning.

That does not answer who had final professional authority.

Layer three: the Company Designee#

One of the most important governance provisions appears early in the agreement.

When the contract calls for CFMG approval, consent, direction or other action — unless the agreement says otherwise — action by the person designated as CFMG’s chief executive officer under its bylaws, termed the Company Designee , can constitute action by CFMG.

The agreement also provides for a management-company representative to attend and participate in certain meetings involving the Company Designee and equityholders, in a non-voting capacity.

This is a governance-adjacent mechanism.

It proves that the management relationship reached beyond isolated back-office tasks.

It does not prove that the manager had a vote or could compel a professional decision.

The public investigation therefore needs to identify:

• who served as Company Designee over time;

• what authority CFMG’s bylaws gave that role;

• and what categories of decisions moved through that approval channel.

Layer nine: insurance, risk, claims and litigation#

The management agreement assigns the manager a role in obtaining or maintaining insurance, risk-management support, and assistance in responding to demands, liability allegations and lawsuits.

That means litigation infrastructure is part of the management architecture.

But claims administration is not automatically the same thing as:

• physician employment authority;

• corporate ownership;

• or clinical control.

This investigation will treat claims and defense as their own authority domain.

It does prove#

• CFMG was structured as a California professional corporation.

• A separate management company supplied extensive services.

• The manager was intended to be deeply integrated into CFMG’s business operations.

• The contract expressly reserved professional medicine to CFMG.

• Several professional/governance functions were specifically assigned to CFMG.

• Employment, systems, finance, risk and records administration were extensively supported by management.

• The management relationship was transferred to Wellpath LLC in 2019.

• related stock-transfer restriction agreements were expressly referenced in the assignment.

Sonoma — clearest current PC/MSO recital#

Sonoma's 2026 MAT agreement is among the strongest current documents because it names CFMG as contractor and separately identifies Wellpath LLC as the Management Services Organization providing functions such as accounting, regulatory support, claims/litigation assistance, payroll, invoicing, risk management, and HR. The same contract separately gives the County powers over staffing, audits, security, and removal of assigned personnel.

This is a clean example of distributed authority , not one actor controlling everything.

Master reader orientation#

The final project conclusion is not that CFMG and Wellpath are “the same entity,” nor that they are operational strangers.

The record supports a layered model:

• CFMG — legally distinct California professional corporation; formal County contractor and strong formal physician-employer evidence; claimed physician-governance authority.

• Wellpath / management entities — extensive MSO/enterprise infrastructure across HR, systems, compensation, credentialing administration, finance, claims, records, litigation, and other operational domains.

• County/client authority — an independent source of contract, security, access, transportation, remedial-plan, and operational requirements.

• Individual licensed clinicians — patient-specific professional judgment and other physician-reserved functions.

The final unresolved issue is function-specific:

When an administrative process reached a decision California reserves to physicians, who possessed practical final approval or veto, and what happened when CFMG and Wellpath disagreed?

December 31, 2012 Management Services Agreement#

An executed Management Services Agreement dated December 31, 2012 is the most important structural document identified so far.

The agreement contains substantial language favoring legality:

• CFMG and the management company are described as separate independent entities.

• CFMG formally employs or engages physicians.

• Professional medical services and medical judgment are reserved to CFMG.

• The management company is prohibited from itself practicing medicine or directly assuming patient-care responsibility.

• The relationship is framed as administrative support rather than professional control.

Those provisions must be given genuine weight.

At the same time, the agreement creates a deeply integrated administrative relationship. The management company is made CFMG's exclusive management-services provider and receives broad responsibilities involving:

• accounting and financial administration;

• payroll and tax functions;

• employee and physician benefit administration;

• physician-employment documentation and policy administration;

• human-resources support;

• staffing analysis;

• physician compensation administration and recommendations;

• billing and coding support;

• information technology;

• electronic health-record systems and operational records;

• county/client contracting support;

• compliance and licensing support;

• insurance and risk-management functions;

• litigation support;

• purchasing and equipment administration;

• banking and budgeting;

• participation in governance-related processes.

This combination—formal reservation of physician authority plus extensive management-company operational authority—is the structural issue that must be tested against actual conduct.

Strongest evidence justifying further control investigation#

Conversely, several facts justify deeper investigation:

• The MSO is CFMG’s exclusive management-services provider.

• A management representative can attend and participate in CFMG equityholder/governance meetings, though without vote.

• CFMG physician employment forms are prepared by management and cannot be amended without management approval.

• The MSA assigns extensive physician HR functions to management.

• The MSA says management will determine physician base and incentive compensation .

• Management participates in staffing deliberations and schedule review.

• Wellpath publicly says it provides CFMG utilization-management functions.

• Management administers EMR systems and supervises storage/maintenance of patient records.

• Management negotiates client agreements and professional-service agreements on CFMG’s behalf.

• Management acquires/holds title to substantial equipment and recommends medical equipment.

• CFMG designated a Wellpath HR executive as Rule 30(b)(6) PMK about a CFMG physician termination.

• That witness testified the physician was terminated by management working for Wellpath.

• The Wellpath enterprise handbook is broad enough on its face to include entities managed by Wellpath LLC, while its exact application to CFMG physicians remains unresolved.

• Contemporaneous California operating records show Wellpath HR, clinical leadership, insurance, claims, and enterprise systems interacting directly with CFMG physician matters.

• The 2019 assignment transferred the MSA together with related stock-transfer restriction agreements into the Wellpath structure.

These facts do not establish illegality. They establish why approval and override evidence is essential.

Cfmg's termination rights are real, but narrowly structured#

Section 5.2 permits CFMG to terminate immediately if the management company materially breaches the MSA, fails to cure within 45 days after written notice, and the breach materially adversely affects CFMG.

The required notice must be executed by the Company Designee to be effective.

CFMG can also terminate if the management company enters specified insolvency proceedings.

This is meaningful termination authority.

It is evidence against an assertion that CFMG had literally no contractual exit right.

But several structural features narrow that freedom.

First, the agreement does not appear to provide CFMG a broad termination-for-convenience right during the term.

Second, CFMG's breach notice must come from the Company Designee.

Third, the management company has its own termination rights.

Fourth, termination of the Deficit Funding Loan Agreement gives the management company an immediate termination right under the MSA.

Fifth, certain breaches can trigger substantial payment consequences.

Accordingly, the proper question is not whether CFMG had some termination right.

It is:

Could the physician corporation realistically choose a new MSO simply because its physicians preferred a different manager?

On the current text, that proposition is not established.

Why the stock-transfer document is different from the MSA#

The Management Services Agreement tells us who administers the business.

The stock-transfer agreement may tell us who ultimately controls the owner of the medical corporation.

That distinction is fundamental.

A lawful MSO can perform extensive administrative services for an independently controlled medical corporation.

Examples may include:

• payroll;

• accounting;

• IT;

• HR administration;

• insurance;

• procurement;

• billing;

• compliance support;

• scheduling support;

• records infrastructure;

• contracting support.

The physician corporation can remain substantively independent if the physician owners retain real authority over professional matters and meaningful governance power over the corporation.

A stock-transfer instrument becomes more consequential because it can affect the person who holds the legal voting stock.

If the MSO merely prevents an unqualified person from inheriting professional-corporation stock and provides an orderly mechanism for transfer to another independently selected qualified physician, the agreement may function as a legitimate compliance and continuity device.

If, by contrast, the MSO can decide who owns the PC, replace the owner at will, or cause the owner to lose stock for challenging the MSO, then the agreement can give the MSO leverage over every decision formally assigned to the physician owner.

The legal inquiry therefore changes from:

“Who performs management services?”

to:

“Who can remove the person who is supposed to control the professional corporation?”

The 2012 management-agreement baseline#

Earlier articles in this series identified the December 31, 2012 Management Services Agreement as the central structural instrument in the modern CFMG–MSO arrangement.

The reviewed project record attributes to that agreement several provisions favoring a lawful PC–MSO architecture:

• CFMG and the management organization are described as separate entities;

• CFMG formally employs or engages physicians;

• professional medical services and medical judgment are reserved to CFMG;

• the management organization is not itself to practice medicine or assume direct patient-care responsibility;

• broad administrative services are delegated to the management side.

The same record describes the management organization as having extensive responsibilities concerning:

• payroll and benefits administration;

• physician-employment documentation;

• HR support;

• staffing analysis;

• compensation administration and recommendations;

• billing and coding support;

• IT and electronic-record systems;

• insurance and risk;

• litigation support;

• contracting;

• purchasing and equipment;

• finance, banking, and budgeting;

• and participation in governance-related processes.

A project submission that reviewed the executed agreement also identifies a potentially important “Company Designee” mechanism, under which certain CFMG actions or approvals may be communicated through a designated CFMG officer or designee and relied upon by the management organization as CFMG action.

That mechanism is not inherently improper. But it makes authentication of the approval chain essential. If CFMG decisions were routinely transmitted through one designee, the investigation must know:

• who held that role at each relevant time;

• whether the designee was a licensed physician;

• what authority had been delegated;

• whether professional decisions could be delegated at all;

• what record showed the underlying physician decision;

• and whether the MSO could act without obtaining a fresh CFMG approval.

The MSA therefore provides the formal hypothesis. the prior analysis tests whether actual conduct matched it.

Evidentiary caution: the standalone executed 2012 MSA has not yet been separately indexed in the current saved Library under an obvious filename. the investigation's existing section-by-section crosswalk should be treated as a strong retrieval guide, while the executed agreement, exhibits, assignments, amendments, and designee records remain Tier-One authentication targets.

Why an override census is more probative than a control narrative#

The phrase “who controlled CFMG?” is too broad to be useful without identifying the function, time, site, and decision.

A professional corporation can lawfully delegate or outsource administrative implementation while retaining protected professional authority. A management organization can also influence outcomes without formally owning the professional decision. The only reliable way to distinguish the two is to reconstruct concrete events.

For each event the record now asks:

• What triggered the decision?

• Who opened the workflow?

• Who developed the factual record?

• Who recommended an outcome?

• Was a professional review required?

• Which licensed physician or physician body performed that review?

• Could that reviewer reject the recommendation?

• Did the reviewer ever ask questions, delay action, impose conditions, modify reasoning, dissent, or say no?

• Who entered the final decision into the operational system?

• Did implementation occur before or after professional approval?

• What happened when the professional and administrative participants disagreed?

The last question is the most valuable.

If Wellpath recommends termination and a CFMG physician body rejects termination, and the physician remains employed, the event strongly supports practical CFMG veto power. If Wellpath proposes a workload target and a CFMG medical director reduces it for safety reasons, and the reduced target governs despite financial cost, that is strong evidence of professional independence. If a Wellpath utilization mechanism initially denies an outside referral and a CFMG physician reverses the denial, that can show physician authority over patient-specific care.

The reverse matters too. If a CFMG physician rejects an administrative recommendation but Wellpath proceeds anyway, or if Wellpath implements a clinically sensitive action before any CFMG physician review, that would weigh in the opposite direction.

Routine concurrence has much less discriminatory value. A physician can agree with an MSO recommendation for legitimate reasons. A long series of unanimous decisions proves little unless the record also shows that disagreement was practically possible.

The California litigation record does not support a single, simple proposition that CFMG and Wellpath are either “the same company” or “completely separate.”

It supports a more disciplined set of propositions that operate at different legal levels.

First, CFMG and Wellpath are legally distinct entities.

Post-bankruptcy litigation makes this unusually clear. Multiple matters had to correct earlier assumptions and add CFMG as a separate non-debtor party after Wellpath's Chapter 11 made entity identity legally consequential.

Second, legal separateness did not prevent extensive operational integration.

Discovery records, stipulations, employment testimony, claims/defense arrangements, shared administrative systems, and county descriptions repeatedly show Wellpath functioning through or alongside CFMG in HR, records, finance, litigation, claims, systems, and other administrative domains.

Third, some litigation positions expressly embraced functional sameness in particular contexts.

The strongest example is \_Smith v. Santa Cruz County\_, where CFMG participated in a case-specific stipulation treating CFMG and Wellpath as the same entity “for all intents and purposes,” and the district court later held CFMG to the breadth of the position it had requested for that litigation.

Fourth, other litigation positions later emphasized separateness.

\_Post-bankruptcy\_ cases such as \_Pugh\_, \_J.S.\_, and \_Reynolds\_ expressly identified CFMG as “separate and distinct” from Wellpath LLC and added or substituted CFMG because Wellpath's bankruptcy revealed that the California professional corporation had not simply disappeared into the debtor enterprise.

Fifth, those positions are not inherently contradictory.

A professional corporation can be a distinct juridical entity while sharing records systems, HR support, insurance, defense, administrative staff, branding, and financial infrastructure with an MSO. The litigation-to-control question is therefore not “Which label is true?” It is:

What control proposition was actually at issue in each case, what source supports it, and how far can the proposition legitimately be carried?

Sixth, the litigation record is much stronger for certain control domains than others.

The record is presently strongest for:

• juridical separateness;

• operational integration;

• HR participation;

• records/discovery integration;

• insurance/indemnity and defense infrastructure;

• public/client identity confusion;

• and context-dependent corporate descriptions.

It is materially weaker for:

• actual CFMG physician veto;

• final clinical-policy approval;

• physician workload override;

• referral/diagnostic authority;

• privileging;

• peer review;

• and the final decision chain for clinically sensitive physician-employment actions.

Seventh, no reviewed California case has been identified as adjudicating that Wellpath unlawfully exercised CFMG's physician-reserved authority under California's corporate-practice rules.

The litigation record contains direct evidence, sworn testimony, stipulations, discovery positions, and structural facts relevant to that question, but it should not be converted into a CPOM merits judgment that does not exist.

The principal synthesis of the prior analysis is:

California litigation proves legal separateness and substantial operational integration at the same time. It also proves that the companies and their counsel have described that relationship differently depending on the function and procedural context. The remaining CPOM question is not resolved by those labels. It depends on the decision rights isolated in earlier articles in this series.

Fresno's strongest evidence that would support practical Wellpath control#

The following would point the other way if established:

• Wellpath operations determine physician patient loads despite CFMG safety objection.

• Wellpath nonphysician administration can finally deny medically necessary referrals.

• Wellpath independently determines a physician is clinically unsafe to return.

• CFMG physician review occurs only after HR/IT action is irreversible.

• Wellpath controls physician privileges rather than credentialing administration only.

• CFMG physician board lacks records, charter, or practical ability to reject recommendations.

• national Wellpath clinical policies bind Fresno without CFMG professional approval.

• Wellpath controls peer-review outcomes.

• CFMG physicians cannot access records needed to exercise supposed authority.

• actual contrary CFMG physician instructions are ignored.

No item should be treated as proved without event-level evidence.

IV. Contrary Evidence, Limits, and Competing Explanations#

A disciplined analysis must begin its limiting case with the strongest contrary evidence: The strongest contrary evidence is the MSA's explicit reservation of professional authority and real termination rights. The article must distinguish structural leverage from proof of an actual unlawful medical decision.

Art Center Holdings#

In April 2026, Attorney General Rob Bonta announced an amicus brief in Art Center Holdings, Inc. v. WCE CA Art . The Attorney General’s public statement emphasized that MSOs may provide administrative and back-office support but cannot own or operate medical practices or exercise undue influence over licensed medical professionals. California DOJ — Apr. 1, 2026

The analysis also focuses attention on contractual rights affecting physician ownership and owner replacement.

That is an important legal lens.

It is not a final appellate holding that every similar contractual feature is unlawful, and it is not evidence that CFMG has the same ownership provisions.

What this legal framework does not prove#

Nothing on this page establishes that:

• Wellpath unlawfully practiced medicine;

• CFMG failed to exercise professional independence;

• a particular management function violated §2400;

• a particular shareholder arrangement was unlawful;

• or a regulator or court has adjudicated the CFMG–Wellpath structure unlawful.

Those are factual and legal conclusions that require CFMG-specific evidence.

The purpose of the framework is to identify what evidence would matter.

The most important development from this analysis is not another malpractice case. It is a pattern of formal identity descriptions that change depending on the legal or institutional context .

Across the period reviewed, the relationship has been described in at least the following ways:

• CFMG as the California professional corporation and Wellpath as its management-services organization;

• CFMG “dba Wellpath” in county contracting records;

• CFMG and Wellpath as “for all intents and purposes” the same entity for purposes of particular litigation and discovery;

• Wellpath and CFMG as having effectively the same recordkeeping, employees, and other functions for discovery purposes;

• CFMG as “separate and distinct” from Wellpath after bankruptcy forced the parties to identify the correct non-debtor California entity;

• CFMG as a “subsidiary company of Wellpath Management Inc.” in a post-bankruptcy Tulare stipulation based on advice reportedly received from bankruptcy counsel;

• CFMG as a “corporate parent” of Wellpath LLC in several Northern District of California interested-entity disclosures;

• CFMG as an “other affiliate” of Wellpath in another federal disclosure;

• Wellpath LLC as an “other affiliate” of CFMG in a 2026 disclosure;

• CFMG as the formal employer in NLRB proceedings while unions and public-facing labor communications identify the workforce as Wellpath workers;

• CFMG as the county contractor while Wellpath is expressly identified by counties as the MSO providing payroll, HR, risk, litigation support, accounting, licensing, and related infrastructure.

These descriptions cannot simply be stacked together as proof that one of them is false. Different legal questions legitimately produce different descriptions. A professional corporation may be a separate juridical entity, use a common brand, outsource extensive administrative functions, participate in a consolidated insurance program, and still remain the lawful physician-controlled medical corporation.

What makes this record important is the repeated difficulty of identifying where formal CFMG authority ends and Wellpath authority begins . That difficulty appears not only in plaintiff pleadings, but in government procurement records, labor records, defense stipulations, bankruptcy papers, corporate-disclosure filings, and the companies’ own operating materials.

This article therefore adopts an additional research rule:

Identity labels are evidence of how the relationship was represented, not proof of how authority was actually allocated.

The final CPOM analysis must turn on decision rights and decision practice , not nomenclature.

B. The 2012 MSA is substantial exculpatory evidence#

the investigation-reviewed MSA contains precisely the provisions one would expect in a lawful California PC–MSO architecture:

• separate-entity language;

• professional independence language;

• formal physician employment by CFMG;

• reservation of professional medical judgment;

• prohibitions on the manager practicing medicine;

• broad but defined administrative services.

The defense should insist that these provisions are not "mere paper."

Contracts are evidence of intended and allocated authority.

A regulator cannot infer that every contractual boundary was ignored merely because the MSO performed many administrative functions.

The agreement's use of an exclusive manager is also not inherently unlawful. Large practices often centralize systems and support functions for efficiency. Exclusivity may be commercially important without transferring professional rights.

V. Missing Documents and Falsification Tests#

The record remains incomplete in material respects. Key unresolved points include Company Designee history, practical MSO replacement, compensation veto, and an actual event where formal professional authority changed management's preferred outcome.

VI. Why the Issue Matters#

The stakes are practical rather than semantic. Counties need to know which entity is accountable for contracted performance; clinicians need to know where professional authority resides; courts and regulators need entity-specific evidence rather than brand shorthand; and the public needs a record that distinguishes corporate continuity from operational integration. Those distinctions become most important when the actors disagree, when a contract changes hands, when a professional decision conflicts with an economic preference, or when litigation requires a precise answer to who had authority to act.

What the Medical Board says physicians must control#

The Medical Board of California’s current corporate-practice guidance makes the line unusually concrete.

The Board says the doctrine is intended to prevent unlicensed persons from interfering with or influencing professional judgment. It identifies several healthcare decisions that should be made by California-licensed physicians:

• appropriate diagnostic testing;

• referrals and specialist consultation;

• responsibility for the patient’s ultimate overall care and treatment options;

• how many patients a physician must see;

• how many hours a physician must work.

The Board then identifies additional “business” or “management” decisions that can amount to control of medical practice, including:

• control of medical records and their contents;

• physician and clinical-staff hiring or firing when clinical competency or proficiency is involved;

• parameters for payer relationships;

• coding and billing procedures;

• selection of medical equipment and supplies.

Medical Board of California — Practice Information

That list is crucial because it prevents two analytical mistakes.

Layer six: physicians are employed or engaged by CFMG — but management shapes the employment architecture#

The agreement says CFMG employs or engages the physicians necessary for the practice.

That is formal evidence of CFMG’s employer role.

But the employment architecture is shared.

The agreement provides that forms of physician employment agreements are prepared through the management organization and approved by CFMG. It further states that CFMG may not amend the form without the manager’s prior written approval.

The manager also provides extensive physician HR support, including categories such as:

• employment policies and forms;

• background-check support;

• orientation;

• benefits administration;

• workers’ compensation and EEO-related administration;

• software education;

• physician database maintenance.

This is a particularly useful example of why “who is the employer?” and “who administers employment?” are not always the same question.

The public contract places CFMG in the physician-employer position while giving the manager a major role in the employment infrastructure.

VII. Falsification Tests and Evidentiary Limits Note#

The record does not support be read as establishing an unproven motive, an undisclosed shareholder, an unlawful medical override, or a legal conclusion that a court or regulator has not made. The strongest version of the thesis is the one that survives the missing-document test: identify the instrument, minutes, ledger, delegation, approval record, or disagreement event that would materially change the conclusion, then state what has and has not been found. If later primary evidence contradicts a proposition stated here, the correction should be made at the proposition level rather than defended through branding or organizational shorthand.

VIII. Related Articles#

• Article 011 — What the MSA Actually Reserves to Physicians

• Article 013 — The Company Designee: The Little-Studied Office at the Center of CFMG Approval

• Article 010 — The 2026 California Stack: CFMG, Wellpath Operations, Enterprise Clinical Leadership, Zenova, and the County

IX. The administrative grant is broad enough to matter without being self-proving#

Article 012 examines the other half of the 2012 bargain: the powers granted to the manager. Those powers are extensive. Finance, accounting, payroll administration, benefits, recruiting support, information systems, records administration, contracting support, insurance, claims, compliance infrastructure, and other business functions can place the manager at the center of day-to-day operations. The breadth of that grant is evidence of operational integration. It is not, by itself, evidence that the manager practiced medicine.

The correct analysis separates capacity to influence from legal authority to decide. Control of data can influence a clinical program because the entity controlling reports determines what decision-makers see. Control of recruiting can influence staffing because the available candidate pool shapes choices. Control of finance can influence service levels because budgets constrain feasible options. Control of HR can influence employment outcomes because investigations and recommendations frame the decision. Yet none of those facts alone establishes who had the final professional authority.

This distinction is central to California's corporate-practice doctrine. The law does not require a physician corporation to perform every clerical or business function internally. Modern medical groups routinely purchase sophisticated management services. The line becomes legally significant when a nonprofessional entity controls decisions that must remain with licensed professionals or uses administrative leverage to dictate professional judgment.

Administrative infrastructure can create practical dependence#

Operational dependence is nevertheless relevant because rights that cannot realistically be exercised may be weaker than they appear on paper. If CFMG relies on the manager for payroll, benefits, IT, records, billing, insurance, recruiting, and county interface, replacing the manager would be a major operational event. The Right-to-Leave inquiry therefore asks whether the corporation has practical access to its own data, records, staff information, contracts, and transition services if the relationship ends.

A lawful structure can be deeply integrated and still provide meaningful exit mechanisms. Transition assistance, data portability, assignment provisions, termination rights, and the ability to contract with a successor MSO would support that conclusion. Conversely, if the professional corporation would lose essential infrastructure or contractual rights upon separation, dependence becomes more significant to the practical-control analysis.

Administrative recommendations require a decision audit#

Where the manager is authorized to recommend action, the analysis must identify whether the recommendation is advisory in practice. A recommendation that can be rejected without retaliation or operational obstruction is different from a recommendation that functions as a directive. The best evidence is a sample of real decisions over time, particularly those where the interests of the professional corporation and manager were not perfectly aligned.

For physician compensation, for example, finance can model market data and budgets while the professional corporation retains the authority California law reserves to the medical practice. For staffing, operations can forecast need and recruiting can source candidates while CFMG makes the professional determination. For quality, enterprise systems can collect data and recommend interventions while the professional body retains responsibility for physician-specific professional action. Each function requires its own record.

The manager's breadth also improves accountability analysis#

The broad grant means the manager should not be treated as an irrelevant outside vendor. If an investigation concerns payroll, benefits, records, IT, insurance, claims, financial administration, or operational systems, Wellpath's management role may be directly material even when CFMG remains the professional employer or contractor. Precision cuts both ways: separateness should not erase genuine management responsibility, just as integration should not erase the professional corporation.

The most defensible conclusion is therefore dual. The 2012 MSA creates a powerful and exclusive management platform around CFMG, making the manager central to operations. At the same time, the agreement expressly preserves a professional domain. The unresolved issue is whether the practical operation of the first domain ever displaced the second. That question belongs to the evidence of actual decisions, not to the width of the administrative-services list alone.

X. Breadth should be measured against reserved outcomes#

The final analytical step is comparative. The wider the administrative grant, the more important it is to identify the professional outcomes the manager cannot lawfully dictate. If the manager controls many inputs but CFMG consistently controls the reserved outcomes, the structure may be highly integrated without crossing the professional boundary. If control of the inputs predictably fixes the outcome before CFMG acts, the formal reservation warrants closer scrutiny.

That comparison should be made with actual records from staffing, compensation, policy, credentialing, peer review, and discipline. A long list of management services is evidence of institutional power; only decision-chain evidence shows whether that power became professional control.

Conclusion#

Article 012 should be published only at the level of confidence the record supports. The controlling proposition is the one stated in the question presented above; adjacent issues such as ownership, employer status, professional authority, bankruptcy treatment, and branding should remain separate unless a primary source supplies the bridge. The strongest contrary evidence belongs in the article, not in an editorial footnote, and any unresolved ownership, delegation, succession, or decision-chain record should remain identified as a document target rather than converted into a factual assertion.

What the September 2026 discharge ruling means for the manager's half#

The manager-side functions this article catalogues sit inside legal entities that a federal court has now sorted by bankruptcy status. In Estate of Jeremiah Wright v. County of Stanislaus, E.D. Cal. No. 2:24-cv-02505, order of September 15, 2026, Wellpath LLC — the assignee of the 2019 management agreement — was dismissed as a discharged Chapter 11 debtor. Wellpath Management, Inc., the predecessor manager, was not dismissed on the present pleadings, because defendants had not shown that plaintiffs could have attributed the alleged conduct to that entity before confirmation. CFMG, the professional corporation, remained.

For the manager's half of the MSA the consequence is precise. The extensive administrative functions the agreement assigns — payroll, human resources, information systems, credentialing administration, billing, compliance support — were performed by the entity that received the 2019 assignment. That entity has now been discharged in at least one California case. Whoever performs those functions today does so either as a reorganised successor whose obligations are governed by the confirmed Plan, or under an arrangement the public record does not disclose.

The asymmetry between the two debtor entities matters here too. If the same administrative function was performed by California Forensic Management Group before 2019 and by Wellpath LLC after, a claim arising from that function may survive against one and not the other, on the same facts, depending on when the claimant could have identified which manager was acting. The manager's half of the agreement is not one counterparty for liability purposes; it is a sequence of entities, and the sequence now has legal consequences.

None of this bears on the professional corporation's half. CFMG was not a debtor, its reserved functions were never in the estate, and the order treats it as a live defendant. The division the 2012 agreement drew — professional judgment to the professional corporation, administration to the manager — is the same line the court drew between discharged and undischarged parties. Whether that alignment reflects the arrangement's design or its accident is a question the discharge ruling does not answer.

Sources and authorities#

1. Source: Medical Board of California www.mbc.ca.gov — https://www.mbc.ca.gov/Licensing/Physicians-and-Surgeons/Practice-Information/
2. BPC §2400 leginfo.legislature.ca.gov — https://leginfo.legislature.ca.gov/faces/codes\_displaySection.xhtml?lawCode=BPC&sectionNum=2400.
3. BPC §2052 leginfo.legislature.ca.gov — https://leginfo.legislature.ca.gov/faces/codes\_displaySection.xhtml?lawCode=BPC&sectionNum=2052.
4. Corporations Code §13401.5 leginfo.legislature.ca.gov — https://leginfo.legislature.ca.gov/faces/codes\_displaySection.xhtml?lawCode=CORP&sectionNum=13401.5.
5. California DOJ — Apr. 1, 2026 oag.ca.gov — https://oag.ca.gov/news/press-releases/attorney-general-bonta-files-amicus-brief-defense-california%E2%80%99s-ban-corporate

Additional legal authority: California Business and Professions Code section 2400 and Medical Board of California guidance on the corporate practice of medicine.